Cardiff Oncology (CRDF) Stock Chart & Stock Price History $3.70 -0.08 (-2.12%) (As of 12/11/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Cardiff Oncology Stock Price Performance 5 Day Performance+60.17%1 Month Performance+17.83%3 Month Performance+44.53%6 Month Performance+25.42%Year-To-Date Performance+150.00%1 Year Performance+191.34% Receive CRDF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cardiff Oncology and its competitors with MarketBeat's FREE daily newsletter. Email Address WARNING: Don’t let the national media distract you (Ad)Millions of traders could get blindsided by this election-year shock on December 18th… And if you do nothing now, you could wind up panicking in the next 30 days… or worse, making a costly mistake.Click here to watch his emergency briefing >>> CRDF Stock Chart for Thursday, December, 12, 2024 CRDF Chart by TradingView Cardiff Oncology Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/11/2024$3.78$3.70-2.12%$4.20$3.607.44 million shs$189.18 million12/10/2024$2.44$3.78+54.92%$4.15$3.2148.62 million shs$193.27 million12/09/2024$2.31$2.44+5.63%$2.53$2.37454,054 shs$124.77 million12/06/2024$2.34$2.31-1.28%$2.49$2.26665,303 shs$118.11 million12/05/2024$2.41$2.34-2.90%$2.46$2.32481,502 shs$119.65 million12/04/2024$2.59$2.41-6.95%$2.58$2.40857,681 shs$123.22 million Get the Latest News and Ratings for CRDF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardiff Oncology and its competitors with MarketBeat's FREE daily newsletter. 12/03/2024$2.66$2.59-2.63%$2.68$2.54493,188 shs$132.43 million12/02/2024$2.61$2.66+1.92%$2.69$2.53506,494 shs$136.01 million11/29/2024$2.54$2.61+2.76%$2.69$2.57297,671 shs$133.45 million11/28/2024$2.54$2.54$2.54$2.44642,785 shs$129.87 million11/27/2024$2.46$2.54+3.25%$2.54$2.44642,785 shs$129.88 million11/26/2024$2.45$2.46+0.41%$2.53$2.38542,673 shs$125.78 million11/25/2024$2.45$2.45$2.63$2.44611,180 shs$125.27 million11/22/2024$2.50$2.45-2.00%$2.57$2.44481,511 shs$125.27 million11/21/2024$2.53$2.50-1.19%$2.59$2.46476,890 shs$127.83 million11/20/2024$2.62$2.53-3.44%$2.66$2.51489,806 shs$129.36 million11/19/2024$2.58$2.62+1.55%$2.70$2.52604,311 shs$133.96 million11/18/2024$2.58$2.58$2.69$2.52511,875 shs$131.93 million11/15/2024$2.84$2.58-9.15%$2.88$2.531.32 million shs$131.92 million11/14/2024$2.97$2.84-4.38%$3.01$2.80508,465 shs$151.87 million11/13/2024$3.14$2.97-5.41%$3.16$2.95841,395 shs$151.86 million11/12/2024$3.46$3.14-9.25%$3.44$3.08815,364 shs$146.17 million11/11/2024$3.08$3.46+12.34%$3.66$3.111.25 million shs$161.06 million Related Companies SIGA Stock Chart RGNX Stock Chart KALV Stock Chart ORGO Stock Chart ZVRA Stock Chart YMAB Stock Chart AKBA Stock Chart TKNO Stock Chart AURA Stock Chart CGC Stock Chart Receive CRDF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cardiff Oncology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRDF) was last updated on 12/12/2024 by MarketBeat.com Staff From Our PartnersEx-Lawyer turns $50k into $5 million tradingHe was a lawyer by day, secret trader by night...or in this case by lunch… With nothing but a laptop and a ...Investing Daily | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredWant to Start Investing? It’s Easier Than You Think!Many people think you need a lot of money to start investing—but that’s simply not true. Andy Tanner, Rich ...The Cashflow Academy | SponsoredPrepare Now Before This Looming $2 Trillion D.C. ShockMillions of traders could get blindsided by this election-year shock on December 18th… And if you do nothin...Timothy Sykes | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiff Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiff Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.